Contents
Pfizer, a company primarily known for producing the COVID-19 vaccine, said it has completed clinical trials on a drug that reduces the risk of severe coronavirus. The number of hospitalizations in the studied patients decreased by 89%. The drug is administered orally.
- Along with the race to vaccinate the world’s population as much as possible, the competition of medical companies for the development of a drug to mitigate the effects of the coronavirus is also underway.
- A few weeks ago we wrote about molnupiravir, a drug for patients infected with coronavirus
- Now Pfizer has informed about its research
- The antiviral drug developed by her is to be even more effective than molnupiravir
- More information can be found on the Onet homepage
The COVID-19 drug from Pfizer – what effects?
Researchers at Pfizer announced that their orally taken antiviral pill cuts 89 percent. the risk of severe course, hospitalization and death in patients infected with the coronavirus.
The anticipated effects are greater than for the drug molnupiravir by Merck & Co Inc., which reduces the risk by half. In both cases, the data provided are preliminary.
Pfizer is due to present the results of its research to the US Food and Drug Administration in order to obtain approval for the preparation in an emergency.
The medicine developed by Pfizer is given together with an older antiviral medicine called ritonavir. This combined treatment, called Paxlovid, consists of three tablets given twice a day.
The rest of the article under the video.
COVID-19 drug from Pfizer – very few hospitalizations
Pfizer’s clinical trial was conducted on 1 thousand. 219 patients at risk of hospitalization or death, with at least one factor in the development of severe disease, such as obesity or older age.
It turned out that only 0,8 percent. people who received Pfizer medicine within three days of onset of symptoms were hospitalized. Neither of them died within 28 days of receiving treatment. For comparison – in patients receiving placebo, the hospitalization rate was 7%. There were also seven deaths.
- The effectiveness of vaccines declines over time. In one of them, the decline is drastic
According to the company, in patients who were given the drug five days after the onset of symptoms, the need for hospitalization occurred in 1% of patients. In the group where placebo was administered, 6,7 percent were hospitalized. people, and 10 died.
The authors of the studies emphasize that the key is to administer the drug as soon as possible.
– We have seen that we are highly effective, even if five days have passed. People sometimes have to wait several days to be tested for COVID-19, and that means we have time to start treating people, Annaliesa Anderson, head of the Pfizer program, told Reuters.
The company did not provide details of the side effects, but said they occurred in 20% of them. both those treated with the drug and those receiving a placebo.
“ These data show that our oral antiviral drug, if approved by regulators, could save many patients’ lives, reduce the severity of COVID-19 infections and eliminate up to nine out of ten hospitalizations, ” added Pfizer CEO Albert Bourla.
- Order COVID-19 Shipment Test today and check for coronavirus.
COVID-19 drugs – how do they work?
Pfizer’s drug belongs to a class known as protease inhibitors. It aims to block an enzyme that the coronavirus needs to multiply.
- The latest COVID-19 infection map. Poland is all red
Merck’s molnupiravir, previously mentioned, has a different mechanism of action. Its effect is to introduce errors into the genetic code of the virus.
Do you want to test your COVID-19 immunity after vaccination? Have you been infected and want to check your antibody levels? See the COVID-19 immunity test package, which you will perform at Diagnostics network points.
Also read:
- Poles are “yes” to the third dose [SONDAŻ]
- Grzesiowski: the virus has not yet said the last word, where there are many infections, we expect new mutations
- Experts: This group should not take the third dose of the vaccine
- Great health knowledge quiz. How many points will you get? [QUIZ]
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.